News
News
Gilead Sciences agrees to buy Immunomedics
[ 2020-09-17 ]
Portuguese PM says AstraZeneca's vaccine-t
[ 2020-09-10 ]
Indian pharma company launches Remdesivir
[ 2020-08-14 ]
COVID-19 vaccine program boosts revenues o
[ 2020-08-12 ]
Beirut explosion raises concern over chemi
[ 2020-08-07 ]
Improving ecology in nation's bay areas pr
[ 2020-07-31 ]
Sandoz and Austrian government announce jo
[ 2020-07-29 ]
China's first SARS-CoV-2 neutralizing anti
[ 2020-07-15 ]
US buys up world stock of COVID-19 drug
[ 2020-07-03 ]
China's inactivated COVID-19 vaccine start
[ 2020-06-24 ]
Sanofi moves to bolster innovation in Chin
[ 2020-06-19 ]
WHO expert says anti-malaria drug to be st
[ 2020-06-18 ]
China's COVID-19 vaccine trial shows promi
[ 2020-05-23 ]
Japan approves Gilead Sciences' remdesivir
[ 2020-05-08 ]
Statement on Positive Data Emerging from N
[ 2020-04-30 ]
CPhI & P-MEC China moves to December date
[ 2020-04-20 ]
Postponement Notice of CAC2020 to be Combi
[ 2020-04-15 ]
Hydroxychloroquine raw materials' prices s
[ 2020-04-10 ]
FDA says Hydroxychloroquine and Chloroquin
[ 2020-03-30 ]
Indian PM Modi announces 21-day lockdown t
[ 2020-03-25 ]
Export rebate rates increased, many chemic
[ 2020-03-20 ]
Oil Down 23 Percent for the Week
[ 2020-03-16 ]
Rescheduling Notice of 21st China Internat
[ 2020-03-11 ]
Trade momentum remains unscathed
[ 2020-02-22 ]
Therapeutic trial results against COVID-19
[ 2020-02-21 ]
  Home      Prev     Next     Last     1/2  27Page
Links:   DUDLEY CHEM     Xintu Chemical    
Copyright: RELYBO PHARMACHEMICAL CO.,LTD.   Add: No.1 Chuangzhi Road, Nanjing(210019), China    苏ICP备20010078号-1Tel: +86-25-87716566    E-mail: sales@relybopharma.com
Copyright: RELYBO PHARMACHEMICAL CO.,LTD.